Exodus Point Capital Management, LP Puma Biotechnology, Inc. Transaction History

Exodus Point Capital Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.29 - $7.4 $67,039 - $115,639	15,627 New	15,627 $83,000
Q2 2022 Aug 19, 2022	SELL	$1.64 - $3.3 $16,526 - $33,254	-10,077 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.13 - $3.24 $199,960 - $304,164	-93,878 Reduced 90.31%	10,077 $29,000
Q4 2021 Feb 11, 2022	SELL	$2.85 - $6.58 $30,101 - $69,497	-10,562 Reduced 9.22%	103,955 $316,000
Q3 2021 Nov 15, 2021	BUY	$6.63 - $9.39 $491,853 - $696,606	74,186 Added 183.94%	114,517 $803,000
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $167,198 - $215,980	-18,619 Reduced 31.58%	40,331 $370,000
Q1 2021 May 17, 2021	BUY	$9.38 - $13.63 $266,851 - $387,759	28,449 Added 93.27%	58,950 $573,000
Q4 2020 Feb 16, 2021	SELL	$7.78 - $12.13 $59,446 - $92,685	-7,641 Reduced 20.03%	30,501 $313,000
Q3 2020 Nov 16, 2020	BUY	$9.5 - $11.14 $55,907 - $65,558	5,885 Added 18.24%	38,142 $385,000
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $226,121 - $427,082	32,257 New	32,257 $336,000
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $214,870 - $354,701	-33,057 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $289,248 - $424,782	33,057 New	33,057 $356,000

30.5M

73.5K

18.5K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $116M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.